Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/139085
Title: | Insights into the role of hepatocyte PPARα activity in response to fasting | Authors: | Régnier, Marion Polizzi, Arnaud Lippi, Yannick Fouché, Edwin Michel, Géraldine Lukowicz, Céline Smati, Sarra Marrot, Alain Lasserre, Frédéric Naylies, Claire Batut, Aurélie Viars, Fanny Bertrand-Michel, Justine Postic, Catherine Loiseau, Nicolas Wahli, Walter Guillou, Hervé Montagner, Alexandra |
Keywords: | Science::Medicine | Issue Date: | 2017 | Source: | Régnier, M., Polizzi, A., Lippi, Y., Fouché, E., Michel, G., Lukowicz, C., . . . Montagner, A. (2018). Insights into the role of hepatocyte PPARα activity in response to fasting. Molecular and Cellular Endocrinology, 471, 75-88. doi:10.1016/j.mce.2017.07.035 | Journal: | Molecular and Cellular Endocrinology | Abstract: | The liver plays a central role in the regulation of fatty acid metabolism. Hepatocytes are highly sensitive to nutrients and hormones that drive extensive transcriptional responses. Nuclear hormone receptors are key transcription factors involved in this process. Among these factors, PPARα is a critical regulator of hepatic lipid catabolism during fasting. This study aimed to analyse the wide array of hepatic PPARα-dependent transcriptional responses during fasting. We compared gene expression in male mice with a hepatocyte specific deletion of PPARα and their wild-type littermates in the fed (ad libitum) and 24-h fasted states. Liver samples were acquired, and transcriptome and lipidome analyses were performed. Our data extended and confirmed the critical role of hepatocyte PPARα as a central for regulator of gene expression during starvation. Interestingly, we identified novel PPARα-sensitive genes, including Cxcl-10, Rab30, and Krt23. We also found that liver phospholipid remodelling was a novel fasting-sensitive pathway regulated by PPARα. These results may contribute to investigations on transcriptional control in hepatic physiology and underscore the clinical relevance of drugs that target PPARα in liver pathologies, such as non-alcoholic fatty liver disease. | URI: | https://hdl.handle.net/10356/139085 | ISSN: | 0303-7207 | DOI: | 10.1016/j.mce.2017.07.035 | Rights: | © 2017 Elsevier B.V. All rights reserved. | Fulltext Permission: | none | Fulltext Availability: | No Fulltext |
Appears in Collections: | LKCMedicine Journal Articles |
SCOPUSTM
Citations
20
25
Updated on Jan 28, 2023
Web of ScienceTM
Citations
10
23
Updated on Jan 26, 2023
Page view(s)
121
Updated on Jan 28, 2023
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.